Stacey Ma, Ph.D., Joins Sana Biotechnology as Executive Vice President, Technical Operations

March 21, 2019


SEATTLE — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines for patients, announced today that Stacey Ma, Ph.D. joined the company as Executive Vice President, Technical Operations, where she will oversee process and analytical development, supply chain, quality, and global manufacturing operations. She will be a member of the Sana Executive Team and report to President and Chief Executive Officer, Steve Harr, M.D.

“Stacey is an extremely talented leader with a successful track record in delivering medicines to patients,” said Steve Harr, Sana President and Chief Executive Officer. “We are thrilled she has joined us to lead our mission of building scalable and cost-efficient manufacturing solutions for modulating genes and using cells as medicines. Her experience, capabilities, and expertise in building and leading teams align with our mission and ability to deliver on the promise of our science.”

Prior to Sana, Dr. Ma was Global Head, Pharma Technical Innovation, Manufacturing, Science and Technology (MSAT) for Genentech, a member of the Roche Group. Over her 22-year career, Dr. Ma has had various leadership roles within both Roche and Genentech in diverse areas such as process development, analytical development, quality, technology innovation, and chemical, manufacturing and controls (CMC) strategy for large and small molecules from pre-IND through early commercialization stages.

“Sana’s team and science have the potential to help define the next era of medicine and impact patients’ lives,” said Dr. Ma. “The ability to manufacture and deliver DNA, RNA, and cells to re-program or replace cells gives Sana the potential to treat diseases that today represent some of the most significant unmet needs. I am excited to join Sana and look forward to working with my colleagues to build solutions to democratize access to these potential medicines.”

Dr. Ma holds a Ph.D. in chemical engineering from Yale University. She is a member of the American Institute for Medical and Biological Engineering College of Fellows. Dr. Ma also co-chaired multiple scientific international conferences and workshops on topics related to CMC development strategies, including several co-sponsored by the U.S. Food and Drug Administration, European Medicines Agency, and the China Food and Drug Administration.

About Sana
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We are a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and changes how we approach treating disease. Sana has operations in Seattle, Wash., Cambridge, Mass. and South San Francisco, Calif.